We are live on ! Find out more
RI

RTW Investments Portfolio holdings

AUM $10B
1-Year Est. Return 135.35%
This Fund
S&P 500
This Quarter Est. Return
+33.59%
1 Year Est. Return
+135.35%
3 Year Est. Return
+383.62%
5 Year Est. Return
+523.94%
10 Year Est. Return
+15,981.64%
AUM
$380M
AUM Growth
+$114M
Cap. Flow
+$37.3M
Cap. Flow %
9.82%
Top 10 Hldgs %
77.18%
Holding
35
New
3
Increased
16
Reduced
6
Closed
7

Top Buys

Rank Stock Value
1
RGNX icon
Regenxbio
RGNX
+$18.8M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$14M
3
MDCO
Medicines Co
MDCO
+$9.05M
4
ATRA icon
Atara Biotherapeutics
ATRA
+$8.88M
5
OSUR icon
OraSure Technologies
OSUR
+$5.86M

Top Sells

Rank Stock Value
1
AVXS
AveXis, Inc. Common Stock
AVXS
+$14M
2
USO icon
United States Oil Fund
USO
+$7.91M
3
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$4.32M
4
OMER icon
Omeros
OMER
+$2.57M
5
BLUE
bluebird bio
BLUE
+$1.49M

Sector Composition

Rank Sector Weight
1 Healthcare 89.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRTS icon
26
Sensus Healthcare
SRTS
$47.9M
$397K 0.1%
90,404
-32,399
-26% -$153K
NTRA icon
27
Natera
NTRA
$38.3B
$281K 0.07%
31,693
– –
SRTSW
28
DELISTED
Sensus Healthcare, Inc. Warrant expiring on 06/08/2020
SRTSW
$136K 0.04%
155,000
– –
MNKD icon
29
PUT
MannKind Corp
MNKD
$1.21B
– –
-87,700
Closed -$279K
OMER icon
30
Omeros
OMER
$857M
– –
-259,039
Closed -$2.57M
USO icon
31
United States Oil Fund
USO
$2.15B
– –
-84,375
Closed -$7.91M
ALPN
32
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-7,500
Closed -$67K
MRTX
33
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-129,697
Closed -$616K
ACHN
34
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-286,285
Closed -$1.18M
BOLD
35
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-20,000
Closed -$365K
1
2

Similar funds

HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
IIM
INTECH Investment Management West Palm Beach, Florida $10.2B AUM 28.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FPAS
Focus Partners Advisor Solutions Saint Louis, Missouri $9.92B AUM 21.52% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
OIA
OneDigital Investment Advisors Overland Park, Kansas $10.2B AUM 16.58% 1-Year Est. Return

RTW Investments's Q1 2017 Portfolio in Review

As of Q1 2017, RTW Investments held 35 positions worth $380M, up 43% from $266M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

RTW Investments deployed $37.3M of net new capital in Q1 2017, opening 3 new positions and adding to 16 existing holdings. Its largest new stake was OraSure Technologies: 566,230 shares worth $7.32M.

By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 90% a quarter earlier.

On the sell side, the largest reduction was AveXis, Inc. Common Stock, an estimated $14M trimmed.

  • RTW Investments's largest Q1 2017 buy was OraSure Technologies: 566,230 shares worth $7.32M.
  • RTW Investments added most to Regenxbio in Q1 2017, an estimated $18.8M increase.
  • RTW Investments's biggest Q1 2017 reduction was AveXis, Inc. Common Stock, cutting an estimated $14M.
  • RTW Investments fully exited United States Oil Fund in Q1 2017, selling an estimated $7.91M.
  • RTW Investments's ten largest holdings make up 77% of its $380M portfolio in Q1 2017.
  • RTW Investments opened 3 new positions and closed 7 in Q1 2017.
  • RTW Investments's portfolio value rose 43% quarter-over-quarter to $380M.

Based on RTW Investments's 13F filing for Q1 2017, filed 15 May 2017.